RIDGEFIELD, CT--(MARKET WIRE)--Jul 19, 2007 -- Restless legs syndrome (RLS) remains a common, yet often undiagnosed, neurological sensorimotor disorder, despite many years of research and increased disease recognition. To help drive understanding and disease awareness among physicians and people with RLS, Boehringer Ingelheim Pharmaceuticals, Inc. has launched an initiative to educate about the symptoms, diagnosis and treatment of RLS including a major direct-to-consumer advertising campaign. For patients and physicians there is a web-based resource available at www.rlsrest.com, providing valuable RLS educational information and tools. In addition the company has developed an RLS Simulator -- a multi-sensory experience simulating a “day in the life” of an RLS patient to help physicians better understand this complicated condition.
